Identification of a competitive HGF antagonist encoded by an alternative transcript

Area of Science:

• Molecular Biology
• Cell Signaling
• Genetics

Background:

• Hepatocyte growth factor (HGF) is a key signaling molecule involved in cell growth and development.
• HGF exerts its effects by binding to its receptor, c-Met.
• Understanding HGF's regulatory mechanisms is crucial for comprehending cell proliferation and tissue regeneration.

Purpose of the Study:

• To identify and characterize naturally occurring variants of hepatocyte growth factor (HGF).
• To investigate the functional role of a newly identified HGF variant.
• To elucidate the mechanism by which this variant interacts with the HGF receptor (c-Met).

Main Methods:

• Analysis of alternative HGF transcripts.
• Assessment of mitogenic activity of the HGF variant.
• Cross-linking studies to determine receptor binding interactions.
• Identification of the HGF receptor as the c-Met protooncogene product.

Main Results:

• A naturally occurring HGF variant was identified, lacking mitogenic activity.
• This truncated HGF variant specifically inhibited HGF-induced mitogenesis.
• The variant competes with native HGF for binding to the c-Met receptor.
• The same gene encodes both the growth factor and its antagonist.

Conclusions:

• A single gene can produce both an active growth factor and its direct inhibitor.
• This HGF variant acts as a natural antagonist to HGF signaling.
• The discovery offers new insights into the regulation of HGF/c-Met pathway.